3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
37
Phase 1
29
Phase 1/2
24
Phase 3
3
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Melanoma
5
Kidney Neoplasms
4
Carcinoma, Renal Cell
4
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Thoracic Neoplasms
1
Skin Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Diseases
1
Liver Neoplasms
1
Interventions
Zoledronic Acid
5
Bevacizumab
3
exemestane
2
Therapeutics
2
Standard of Care
2
Pamidronate
2
Oxaliplatin
2
Misoprostol
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Ibandronic Acid
2
Fulvestrant
2
Fluorouracil
2
Cetuximab
2
Capecitabine
2
vandetanib
1
palbociclib
1
liposomal doxorubicin
1
huaier
1
eribulin
1
enzalutamide
1
darolutamide
1
cabozantinib
1
aldesleukin
1
abemaciclib
1
Vindesine
1
Trastuzumab
1
Sugars
1
Stents
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasm Metastasis
×
Nivolumab
×
Clear all
NCT07028125
2026-06-05
CANIQOL
Centre Francois Baclesse
Phase 4
Recruiting
83 enrolled